Anis Ahmad1, Junwei Shi1, Saba Ansari1, Jumana Afaghani1, Judith Molina2, Alan Pollack1, Sandra Merscher2, Youssef H Zeidan3, Alessia Fornoni2, Brian Marples1,2,4. 1. Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA. 2. Katz Family Division of Nephrology and Hypertension, Department of Medicine, Peggy and Harold Katz Family Drug Discovery Center, University of Miami, Miami, FL, USA. 3. Department of Radiation Oncology, Anatomy, Cell Biology, and Physiology, American University of Beirut School of Medicine, Beirut, Lebanon. 4. Department of Radiation Oncology, University of Rochester, Rochester, NY, USA.
Abstract
PURPOSE: The kidney is a radiosensitive late-responding normal tissue. Injury is characterized by radiation nephropathy and decline of glomerular filtration rate (GFR). The current study aimed to compare two rapid and cost-effective methodologies of assessing GFR against more conventional biomarker measurements. METHODS: C57BL/6 mice were treated with bilateral focal X-irradiation (1x14Gy or 5x6Gy). Functional measurements of kidney injury were assessed 20 weeks post-treatment. GFR was estimated using a transcutaneous measurement of fluorescein-isothiocyanate conjugated (FITC)-sinistrin renal excretion and also dynamic contrast-enhanced CT imaging with a contrast agent (ISOVUE-300 Iopamidol). RESULTS: Hematoxylin and eosin (H&E) and Periodic acid-Schiff staining identified comparable radiation-induced glomerular atrophy and mesangial matrix accumulation after both radiation schedules, respectively, although the fractionated regimen resulted in less diffuse tubulointerstitial fibrosis. Albumin-to-creatinine ratios (ACR) increased after irradiation (1x14Gy: 100.4 ± 12.2 µg/mg; 6x5Gy: 80.4 ± 3.02 µg/mg) and were double that of nontreated controls (44.9 ± 3.64 µg/mg). GFR defined by both techniques was negatively correlated with BUN, mesangial expansion score, and serum creatinine. The FITC-sinistrin transcutaneous method was more rapid and can be used to assess GFR in conscious animals, dynamic contrast-enhanced CT imaging technique was equally safe and effective. CONCLUSION: This study demonstrated that GFR measured by dynamic contrast-enhanced CT imaging is safe and effective compared to transcutaneous methodology to estimate kidney function.
PURPOSE: The kidney is a radiosensitive late-responding normal tissue. Injury is characterized by radiation nephropathy and decline of glomerular filtration rate (GFR). The current study aimed to compare two rapid and cost-effective methodologies of assessing GFR against more conventional biomarker measurements. METHODS: C57BL/6 mice were treated with bilateral focal X-irradiation (1x14Gy or 5x6Gy). Functional measurements of kidney injury were assessed 20 weeks post-treatment. GFR was estimated using a transcutaneous measurement of fluorescein-isothiocyanate conjugated (FITC)-sinistrin renal excretion and also dynamic contrast-enhanced CT imaging with a contrast agent (ISOVUE-300 Iopamidol). RESULTS: Hematoxylin and eosin (H&E) and Periodic acid-Schiff staining identified comparable radiation-induced glomerular atrophy and mesangial matrix accumulation after both radiation schedules, respectively, although the fractionated regimen resulted in less diffuse tubulointerstitial fibrosis. Albumin-to-creatinine ratios (ACR) increased after irradiation (1x14Gy: 100.4 ± 12.2 µg/mg; 6x5Gy: 80.4 ± 3.02 µg/mg) and were double that of nontreated controls (44.9 ± 3.64 µg/mg). GFR defined by both techniques was negatively correlated with BUN, mesangial expansion score, and serum creatinine. The FITC-sinistrin transcutaneous method was more rapid and can be used to assess GFR in conscious animals, dynamic contrast-enhanced CT imaging technique was equally safe and effective. CONCLUSION: This study demonstrated that GFR measured by dynamic contrast-enhanced CT imaging is safe and effective compared to transcutaneous methodology to estimate kidney function.
Authors: Sebastiaan L Knijnenburg; Monique W Jaspers; Helena J van der Pal; Antoinette Y Schouten-van Meeteren; Antonia H Bouts; Jan A Lieverst; Arend Bökenkamp; Caro C E Koning; Foppe Oldenburger; James C H Wilde; Flora E van Leeuwen; Huib N Caron; Leontien C Kremer Journal: Clin J Am Soc Nephrol Date: 2012-07-19 Impact factor: 8.237
Authors: Ji Youn Lee; Jae Min Jeong; Young Ju Kim; Hyuk-Jin Jeong; Yun-Sang Lee; Dong Soo Lee; June-Key Chung Journal: Nucl Med Biol Date: 2013-12-01 Impact factor: 2.408
Authors: Anna Imhof; Philippe Brunner; Nicolas Marincek; Matthias Briel; Christian Schindler; Helmut Rasch; Helmut R Mäcke; Christoph Rochlitz; Jan Müller-Brand; Martin A Walter Journal: J Clin Oncol Date: 2011-05-09 Impact factor: 44.544
Authors: Frank G Zöllner; Daniel Schock-Kusch; Sandra Bäcker; Sabine Neudecker; Norbert Gretz; Lothar R Schad Journal: PLoS One Date: 2013-11-18 Impact factor: 3.240